BIOS Capital Management, LP Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$82.6M

Holdings

6

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACTUACTUATE THERAPEUTICS INC
10,049,996$61.5M74.44%
2
CGTXCOGNITION THERAPEUTICS INC
6,000,000$8.1M9.80%
3
IRDOPUS GENETICS INC
3,683,429$7.4M8.96%
4
LTRNLANTERN PHARMA INC
1,009,507$3.1M3.70%
5
RNTXREIN THERAPEUTICS INC
1,690,751$2.0M2.37%
6
INABIN8BIO INC
253,417$592K0.72%